Reducing dropout in acceptance and commitment therapy, mindfulness-based cognitive therapy, and problem-solving therapy for chronic pain and cancer patients using motivational interviewing.

CONCLUSIONS: A brief MI telephone intervention may improve adherence to group CBTs in cancer and chronic pain. PRACTITIONER POINTS: A brief motivational interviewing (MI) telephone intervention may reduce dropout from group cognitive-behavioural therapies (CBTs) for cancer and chronic pain patients when administered after the first group session in routine care. Recipients of this intervention were five times more likely to complete a group CBT programme than those who did not receive it. Therefore, a minimal-dose MI intervention can have clinically important effects on dropout in group CBTs for patients with long-term conditions. It is unclear whether this intervention would also result in greater outcome improvements. PMID: 32478862 [PubMed - as supplied by publisher]
Source: The British Journal of Clinical Psychology - Category: Psychiatry & Psychology Authors: Tags: Br J Clin Psychol Source Type: research

Related Links:

Source: CDC Preventing Chronic Disease - Category: International Medicine & Public Health Tags: Public Health Source Type: news
AbstractChronic pancreatitis is a clinical entity that results from the progressive inflammation and irreversible fibrosis of the pancreas resulting from the cumulative injury sustained by the pancreas over time. It is an illness with variable presentations that can severely impact quality of life, while its long-term complications such as exocrine pancreatic insufficiency (EPI), diabetes mellitus, and risk of pancreatic cancer can become life threatening. The diagnosis of chronic pancreatitis can be challenging as despite the recent advancements in imaging technology, the radiographic findings do not become prominent unti...
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
Conditions:   Cancer;   Chronic Pain;   Neuropathic Pain;   Opioid Use Intervention:   Drug: Ketamine use in CLCC sites (indication and administration protocol) Sponsor:   Centre Leon Berard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Chronic Pain Interventions:   Other: Low glycemic load;   Other: High glycemic load Sponsors:   Vrije Universiteit Brussel;   KU Leuven Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Cancer;   Chronic Pain;   Neuropathic Pain;   Opioid Use Intervention:   Drug: Ketamine use in CLCC sites (indication and administration protocol) Sponsor:   Centre Leon Berard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Chronic Pain Interventions:   Other: Low glycemic load;   Other: High glycemic load Sponsors:   Vrije Universiteit Brussel;   KU Leuven Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Cancer;   Chronic Pain;   Neuropathic Pain;   Opioid Use Intervention:   Drug: Ketamine use in CLCC sites (indication and administration protocol) Sponsor:   Centre Leon Berard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Chronic Pain Interventions:   Other: Low glycemic load;   Other: High glycemic load Sponsors:   Vrije Universiteit Brussel;   KU Leuven Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
  Lockdown is a “prison like” experience, for Londoner Annabelle Ume, who suffers from myalgic encephalomyelitis. “It’s very similar to being trapped in a bunker with no access outside,” says Ume.   Many other fellow sufferers are enduring pandemic enforced isolation without much hope. “They are staying in limbo until help is available and adapting to the worsening of their health conditions,” says Ume. “You just try to make mental peace with it because the physical can’t be addressed at this time.” COPD sufferer John Linnell from Wisconsin i...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news
(Society of Nuclear Medicine and Molecular Imaging) SNMMI's Virtual Annual Meeting will convene more than 6,000 attendees from around the globe to share novel research on new and better ways to diagnose and treat cancers, inflammation, arthritis, chronic pain, stroke, brain disease, and more.The focus is on precision medicine--improving patients' lives by developing new ways to diagnose earlier and more accurately, delivering the most effective therapy for a specific patient's disease, and monitoring and adjusting treatment to ensure optimum results.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Behavioural Therapy | Cancer | Cancer & Oncology | Chronic Pain | Cognitive Behavior Therapy | Men | Pain | Psychology | Study | UK Health